Colorectal Cancer Trial, Recruiting NCT07192055 Sponsor: Medical College of Wisconsin Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07192055
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are HIV-positive and aged 35 or older, or people who are HIV-negative and aged 45 or older
  • People who are cisgender or transgender gay, bisexual, or other men who have sex with men, or transgender women who have sex with men
  • People who currently live in the Chicago, Houston, or Milwaukee area
  • People who are willing to attend appointments at a study clinic
  • People who speak and understand English or Spanish
  • People who are able to understand and sign a written consent form agreeing to take part

Who may not be able to join:

  • People who previously took part in the PAC Self-Swab Study in Milwaukee
  • People who are currently taking blood-thinning medications (not including aspirin or common pain relievers like ibuprofen or naproxen)
  • People who have been diagnosed with hemophilia, cirrhosis with bleeding varices (enlarged, fragile blood vessels in the digestive tract linked to liver disease), or a condition involving low platelet counts in the blood
  • People who have a serious medical condition or physical issue that the trial team determines would prevent safe participation — for example, a narrowing of the anal canal (confirm with trial site)
  • People who plan to move away from their current area within 12 months of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alan Nyitray, PhD, Medical College of Wisconsin

Phone: 4149557701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical College of Wisconsin
Registry
ClinicalTrials.gov
Start date
18 November 2025
Est. completion
31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effect of the self-sampling intervention at cytology; Effect of self-sampling intervention at high-resolution anoscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov